Ingevity Corporation

NGVT

US45688C1071

Diversified Chemicals

Market Closed - Nyse Other stock markets 04:00:02 2024-05-10 pm EDT			5-day change	1st Jan Change
54.48 ^USD	+0.02%		+1.72%	+15.37%

May. 07	Loop Capital Adjusts Price Target on Ingevity to $56 From $49, Maintains Hold Rating	MT
May. 02	Transcript : Ingevity Corporation, Q1 2024 Earnings Call, May 02, 2024

Inclusive Capital Partners Provides Information to Shareholders of Ingevity Corporation

July 27, 2022 at 04:16 pm EDT

On July 27, 2022, Inclusive Capital Partners, L.P. announced that on July 25, 2022, William J. Slocum, a Partner at In-Cap, was appointed as a member of the board of directors of Ingevity Corporation.

Latest news about Ingevity Corporation

Loop Capital Adjusts Price Target on Ingevity to $56 From $49, Maintains Hold Rating	May. 07	MT
Transcript : Ingevity Corporation, Q1 2024 Earnings Call, May 02, 2024	May. 02
Oppenheimer Adjusts Ingevity Price Target to $58 From $50, Maintains Outperform Rating	May. 02	MT
Earnings Flash (NGVT) INGEVITY CORPORATION Reports Q1 Revenue $340.1M, vs. Street Est of $319.2M	May. 01	MT
Earnings Flash (NGVT) INGEVITY CORPORATION Posts Q1 EPS $0.52, vs. Street Est of $0.25	May. 01	MT
Ingevity Corporation Reiterates Earnings Guidance for the Full Year 2024	May. 01	CI
Ingevity Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 01	CI
Ingevity Shares Rise After Jefferies Upgrades Stock to Buy From Hold, Raises Price Target	Apr. 22	MT
Jefferies Upgrades Ingevity to Buy From Hold, Raises Price Target to $62 From $52	Apr. 22	MT
Ingevity Corporation Announces Resignation of William J. Slocum from Board	Mar. 14	CI
Transcript : Ingevity Corporation, Q4 2023 Earnings Call, Feb 22, 2024	Feb. 22
Earnings Flash (NGVT) INGEVITY CORPORATION Posts Q4 EPS $0.21	Feb. 21	MT
Earnings Flash (NGVT) INGEVITY CORPORATION Reports Q4 Revenue $371.7M, vs. Street Est of $332.6M	Feb. 21	MT
Tranche Update on Ingevity Corporation's Equity Buyback Plan announced on August 2, 2022.	Feb. 21	CI
Ingevity Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 21	CI
Ingevity Corporation Provides Earnings Guidance for the Year 2024	Feb. 21	CI
Ingevity Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 21	CI
Activist investor Ubben shutting down Inclusive Capital -WSJ	Nov. 29	RE
Ingevity Extends TRiiSO Collaboration to Expand Capa Distribution Through North America	Nov. 28	MT
Ingevity Corporation Extends Partnership with TRiiSO, LLC, Expands Capa®? Distribution Footprint for Customers in the United States and Canada	Nov. 28	CI
Transcript : Ingevity Corporation, Q3 2023 Earnings Call, Nov 02, 2023	Nov. 02
Earnings Flash (NGVT) INGEVITY CORPORATION Reports Q3 EPS $1.21, vs. Street Est of $1.23	Nov. 01	MT
Earnings Flash (NGVT) INGEVITY CORPORATION Posts Q3 Revenue $446M, vs. Street Est of $464.7M	Nov. 01	MT
Tranche Update on Ingevity Corporation's Equity Buyback Plan announced on August 2, 2022.	Nov. 01	CI
Ingevity Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 01	CI

Chart Ingevity Corporation

Duration

Period

More charts

Company Profile

Ingevity Corporation is engaged in developing, marketing, and bringing to market solutions that are renewably sourced. The Company operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. Performance Materials segment engineers, manufactures, and sells hardwood-based, chemically activated carbon products, which are produced through a technical and specialized process primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. Performance Chemicals segment is comprised of two product lines: road technologies and industrial specialties. Its products are utilized in pavement construction, preservation, reconstruction and recycling, agrochemical dispersants, paper chemicals and other diverse industrial uses. Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices.

Sector

Diversified Chemicals

Calendar

2024-07-30 - Q2 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Ingevity Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

54.48 USD

Average target price

62.14 USD

Spread / Average Target

+14.07%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diversified Chemicals

	1st Jan change	Capi.
INGEVITY CORPORATION	+15.37%	1.98B
SHIN-ETSU CHEMICAL CO., LTD.	-1.96%	74.28B
BASF SE	+0.05%	46.91B
DUPONT DE NEMOURS, INC.	+2.38%	32.93B
PIDILITE INDUSTRIES LIMITED	+7.54%	17.78B
BRENNTAG SE	-6.58%	12.09B
EASTMAN CHEMICAL COMPANY	+12.48%	11.88B
SYENSQO SA/NV	-0.23%	10.66B
ASAHI KASEI CORPORATION	+3.37%	9.55B
MITSUBISHI CHEMICAL GROUP CORPORATION	+5.01%	8.28B

Diversified Chemicals

Ingevity Corporation

Equities

NGVT

US45688C1071

Diversified Chemicals

Inclusive Capital Partners Provides Information to Shareholders of Ingevity Corporation

EPS Revisions